SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,543,000 | +15.1% | 7,886 | 0.0% | 1.08% | +5.2% |
| Q2 2020 | $1,340,000 | +41.8% | 7,886 | -3.7% | 1.03% | +49.2% |
| Q1 2020 | $945,000 | +24.2% | 8,186 | +22.9% | 0.69% | +37.3% |
| Q4 2019 | $761,000 | +41.4% | 6,658 | +5.6% | 0.50% | +31.4% |
| Q3 2019 | $538,000 | +17.5% | 6,305 | -4.8% | 0.38% | +19.7% |
| Q2 2019 | $458,000 | +40.1% | 6,622 | +48.3% | 0.32% | +28.1% |
| Q1 2019 | $327,000 | +29.2% | 4,464 | 0.0% | 0.25% | +10.2% |
| Q4 2018 | $253,000 | -28.3% | 4,464 | -2.4% | 0.23% | -14.4% |
| Q3 2018 | $353,000 | -14.5% | 4,576 | -30.4% | 0.26% | -20.5% |
| Q1 2017 | $413,000 | – | 6,570 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |